Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Hypermethylation in histologically distinct classes of breast cancer.

Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, Gabrielson E.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5998-6005.

2.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

3.

Promoter hypermethylation profile of kidney cancer.

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9.

4.

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

Roll JD, Rivenbark AG, Jones WD, Coleman WB.

Mol Cancer. 2008 Jan 25;7:15. doi: 10.1186/1476-4598-7-15.

5.

Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.

Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.

Clin Cancer Res. 2005 Mar 15;11(6):2156-62.

6.
7.

The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.

Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.

Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.

8.
9.

Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.

Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2005 Feb 15;11(4):1380-5.

10.

Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.

Ahmed IA, Pusch CM, Hamed T, Rashad H, Idris A, El-Fadle AA, Blin N.

Cancer Genet Cytogenet. 2010 Jun;199(2):96-100. doi: 10.1016/j.cancergencyto.2010.02.007.

PMID:
20471512
11.
12.

Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.

Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S.

Clin Cancer Res. 2004 Mar 15;10(6):2052-7.

13.

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.

Parrella P, Poeta ML, Gallo AP, Prencipe M, Scintu M, Apicella A, Rossiello R, Liguoro G, Seripa D, Gravina C, Rabitti C, Rinaldi M, Nicol T, Tommasi S, Paradiso A, Schittulli F, Altomare V, Fazio VM.

Clin Cancer Res. 2004 Aug 15;10(16):5349-54.

14.

Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.

Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Mod Pathol. 2012 Feb;25(2):185-96. doi: 10.1038/modpathol.2011.160. Epub 2011 Oct 28.

15.

Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.

Magdinier F, Ribieras S, Lenoir GM, Frappart L, Dante R.

Oncogene. 1998 Dec 17;17(24):3169-76.

16.

Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP.

Breast Cancer Res. 2009;11(1):R14. doi: 10.1186/bcr2233. Epub 2009 Feb 27.

17.

DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.

Bernal C, Vargas M, Ossandón F, Santibáñez E, Urrutia J, Luengo V, Zavala LF, Backhouse C, Palma M, Argandoña J, Aguayo F, Corvalán A.

Biol Res. 2008;41(3):303-15. doi: /S0716-97602008000300007. Epub 2009 Apr 23.

18.

CpG methylation of the ERalpha and ERbeta genes in breast cancer.

Kim SJ, Kim TW, Lee SY, Park SJ, Kim HS, Chung KW, Lee ES, Kang HS.

Int J Mol Med. 2004 Aug;14(2):289-93.

PMID:
15254780
19.

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.

Clin Cancer Res. 2005 Aug 1;11(15):5365-9.

20.

Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, Hunt KK, Bast RC Jr, Shen Y, Issa JP, Yu Y.

Breast Cancer Res. 2007;9(4):R57.

Supplemental Content

Support Center